Tech Center 3700 • Art Units: 3686 3774
This examiner grants 74% of resolved cases
Suba Ganesan is an examiner in Tech Center 3700 and Art Unit 3686. With 682 resolved cases, Ganesan has an allowance rate of 73.8 percent. This 73.8 percent allowance rate suggests a favorable probability of success for applicants. The volume of 682 resolved cases provides a robust statistical foundation for these performance metrics.
The data shows an interview lift of 13.4 percent. This 13.4 percent lift indicates that conducting an interview with the examiner is associated with a higher likelihood of allowance compared to cases without an interview. Practitioners can use this information to justify the time and expense of an interview to their clients. The 13.4 percent lift suggests that direct communication is a useful tactic for resolving issues in Art Unit 3686.
The median time to allowance is 1219 days. This 1219 day period is the typical duration from filing to patent issuance. Applicants should factor this 1219 day median into their prosecution budgets and expectations. With 682 resolved cases, this timing metric is a reliable indicator of the examiner's typical pace.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18411695 | STENT-VALVES FOR VALVE REPLACEMENT AND ASSOCIATED METHODS AND SYSTEMS FOR SURGERY | Final Rejection | Boston Scientific Medical Device Limited |
| 19540505 | DEVICES, SYSTEMS, AND METHODS FOR AN IMPLANTABLE HEART-VALVE ADAPTER | Non-Final OA | ReValve Solutions, Inc. |
| 19346566 | Devices, Systems, and Methods for an Implantable Heart-Valve Adapter | Non-Final OA | ReValve Solutions, Inc. |
| 18422384 | PROSTHETIC VALVES WITH MECHANISMS FOR CONTROLLED EXPANSION | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18448726 | PROSTHETIC VALVES | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18181521 | COMPRESSIBLE SHUNT IMPLANT | Final Rejection | EDWARDS LIFESCIENCES CORPORATION |
| 17826029 | PROSTHETIC HEART VALVES WITH COMMISSURE POST PROTRUSIONS FOR COMMISSURE ASSEMBLY POSITION LOCKING | Final Rejection | Edwards Lifesciences Corporation |
| 18812211 | METHODS AND APPARATUS FOR PREDICTING DECOUPLING DURING NON-CARDIAC MEDICAL PROCEDURES | Non-Final OA | Abiomed, Inc. |
| 18035913 | SYSTEMS AND METHODS FOR MANUFACTURING PROSTHETIC HEART VALVES USING A SINGLE-PIECE VALVE SUBASSEMBLY | Non-Final OA | Medtronic, Inc. |
| 17849565 | BIOHYBRID HEART VALVE REPLACEMENT | Final Rejection | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18043480 | PROSTHETIC CARDIAC VALVE DELIVERY SYSTEMS AND METHODS | Final Rejection | SHIFAMED HOLDINGS, LLC |
| 18441543 | Fibrosis Model On A Chip | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18035509 | TRANSCATHETER DEVICE FOR TREATING TRICUSPID VALVE REGURGITATION | Final Rejection | TAU MEDICAL INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy